A Phase 2 Safety, Tolerability, PK, and Efficacy Study of CS-1103 Following Fentanyl Challenge With Naloxone Blockade

NCT07459166 · clinicaltrials.gov ↗
PHASE2
Phase
NOT_YET_RECRUITING
Status
16
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Clear Scientific, Inc.

Collaborators